Market capitalization | $375.32m |
Enterprise Value | $639.31m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 7.05 |
EV/Sales (TTM) EV/Sales | 0.36 |
P/S ratio (TTM) P/S ratio | 0.21 |
P/B ratio (TTM) P/B ratio | 0.53 |
Dividend yield | 3.18% |
Last dividend (FY24) | $0.24 |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
2 Analysts have issued a Nu Skin Enterprises, Inc. Class A forecast:
2 Analysts have issued a Nu Skin Enterprises, Inc. Class A forecast:
Sep '24 |
+/-
%
|
||
Revenue | 1,775 1,775 |
11%
11%
|
|
Gross Profit | 1,255 1,255 |
9%
9%
|
|
EBITDA | 155 155 |
29%
29%
|
EBIT (Operating Income) EBIT | 84 84 |
4%
4%
|
Net Profit | -103 -103 |
276%
276%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Nu Skin Enterprises, Inc. develops and distributes personal care products and nutritional supplements. The firm engages in the provision of beauty and wellness products and solutions. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.
Head office | United States |
CEO | Ryan Napierski |
Employees | 15,200 |
Founded | 1984 |
Website | www.nuskin.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.